DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,289 | -20.4% | 2,376 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $26,730 | +13.2% | 2,376 | +15.9% | 0.00% | 0.0% |
| Q1 2023 | $23,616 | -0.6% | 2,050 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $23,760 | -27.5% | 2,050 | -20.6% | 0.00% | -50.0% |
| Q3 2022 | $32,791 | +84.9% | 2,582 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $17,738 | -28.7% | 2,582 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $24,890 | -78.6% | 2,582 | -73.6% | 0.00% | -50.0% |
| Q4 2021 | $116,070 | +1.6% | 9,762 | +38.7% | 0.00% | 0.0% |
| Q3 2021 | $114,281 | -41.1% | 7,037 | -23.7% | 0.00% | -33.3% |
| Q2 2021 | $193,926 | +76.7% | 9,217 | +76.4% | 0.00% | +50.0% |
| Q4 2020 | $109,746 | – | 5,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |